Hello mooers, welcome to another week of the FDA calendar. Here are what happened last week and what's coming up this week. Top Medical News of the Week Merck Q3 earnings top Wall Street’s expectations Merck stock surged within a buy zone Thursday after the pharma giant notched a third-quarter beat on particularly strong performances from Keytruda and Gardasil. Revenue from blockbuster cancer drug Keytruda soared 20% during the quarter, leading a ...
Gainers: •$Kezar Life Sciences(KZR.US)$+92% (announces positive top line results from the MISSION Phase 2 trial) •$Sutro Biopharma(STRO.US)$+24.5% (Sutro Biopharma and Astellas to collaborate to advance novel immunostimulatory antibody-drug conjugates) •$Ceragon(CRNT.US)$+17.7% (AVNW to acquire all shares of CRNT that it does not already own for $2.80/sh) •$攜程網(TCOM.US)$+15.6% (In reaction to earnings/guidance) •$Apyx Medical(APYX.US)$+8% (anno...
Kezar Life Sciences股票討論區
He just sold
since I'm Evan McCullouch fans, and ever said he bought $Kezar Life Sciences(KZR.US)$ ... for biotech...
recently he just sold.
If if if Lmdx really go crazy like how I predicted, this 2 ticker will go crazy as well
$Kezar Life Sciences(KZR.US)$
$LumiraDx(LMDX.US)$
🛫
good stock, maybe longer term hold
.
專欄Weekly FDA Drug Pipeline Calendar (Oct 31- Nov 4)
Top Medical News of the Week
Merck Q3 earnings top Wall Street’s expectations
Merck stock surged within a buy zone Thursday after the pharma giant notched a third-quarter beat on particularly strong performances from Keytruda and Gardasil.
Revenue from blockbuster cancer drug Keytruda soared 20% during the quarter, leading a ...
專欄Today's pre-market stock movers: TCOM, OXY, SAVE, GS and more
• $Kezar Life Sciences(KZR.US)$ +92% (announces positive top line results from the MISSION Phase 2 trial)
• $Sutro Biopharma(STRO.US)$ +24.5% (Sutro Biopharma and Astellas to collaborate to advance novel immunostimulatory antibody-drug conjugates)
• $Ceragon(CRNT.US)$ +17.7% (AVNW to acquire all shares of CRNT that it does not already own for $2.80/sh)
• $攜程網(TCOM.US)$ +15.6% (In reaction to earnings/guidance)
• $Apyx Medical(APYX.US)$ +8% (anno...
專欄Today's pre-market stock movers: AMD, SBUX, ABNB, MRNA and more
• $Livent(LTHM.US)$ +22.58% (it posted better-than-expected quarterly earnings and raised its 2022 revenue forecast)
• $超微電腦(SMCI.US)$ +11.01% (earnings reports)
• $Oatly Group AB(OTLY.US)$ +8.31% (earnings reports)
• $布魯林克斯(BXC.US)$ +9.7% (increases share repurchase authorization to $100 mln; enters into $60 mln accelerated repurchase agreement)
• $星巴克(SBUX.US)$ +7.18% (matched estimates wi...
暫無評論